BofA Securities Downgrades Amphastar Pharmaceuticals (AMPH) to Underperform
BofA Securities analyst Jason Gerberry downgraded Amphastar Pharmaceuticals (NASDAQ: AMPH) from ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)